Does the hepatocellular phase of gadobenate dimeglumine help to differentiate hepatocellular carcinoma in cirrhotic patients according to histological grade?

Clinical Radiology

Volumn 66, Issue 9, 2011, Pages 845-852

  Tahir, B ^a   Sandrasegaran, K ^a   Ramaswamy, R ^a   Bertrand, K ^a   Mhapsekar, R ^a   Akisik, F M ^a   Saxena, R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 79960545910     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2011.03.021     Document Type: Article

References (40)

1. J.A. Marrero, H.K. Hussain, and H.V. Nghiem Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass Liver Transpl 11 2005 281 289 (Pubitemid 40458400)
2. S. Monzawa, T. Ichikawa, and H. Nakajima Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging AJR Am J Roentgenol 188 2007 147 153 (Pubitemid 46012501)
3. J.M. Willatt, H.K. Hussain, and S. Adusumilli MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies Radiology 247 2008 311 330
4. A.M. Lutz, J.K. Willmann, and K. Goepfert Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging Radiology 237 2005 520 528 (Pubitemid 41507889)
5. T. Murakami, T. Kim, and M. Takamura Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT Radiology 218 2001 763 767 (Pubitemid 32172560)
6. B.K. Kim, K.H. Han, and Y.N. Park Prediction of microvascular invasion before curative resection of hepatocellular carcinoma J Surg Oncol 97 2008 246 252
7. L. Zhou, J.A. Rui, and D.X. Ye Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection World J Surg 32 2008 1748 1756
8. T.M. Pawlik, K.A. Delman, and J.N. Vauthey Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma Liver Transpl 11 2005 1086 1092 (Pubitemid 41341758)
9. S. Ariizumi, K. Takasaki, and M. Yamamoto Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas Hepatogastroenterology 51 2004 500 504 (Pubitemid 38445305)
10. H. Nathan, R.D. Schulick, and M.A. Choti Predictors of survival after resection of early hepatocellular carcinoma Ann Surg 249 2009 799 805
11. L. Zhou, J.A. Rui, and S.B. Wang Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection J Surg Oncol 95 2007 298 303 (Pubitemid 46355505)
12. J.R. Parfitt, P. Marotta, and M. Alghamdi Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence Liver Transpl 13 2007 543 551 (Pubitemid 46605857)
13. R.T. Poon, S.T. Fan, and C.M. Lo Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival Ann Surg 245 2007 51 58 (Pubitemid 46035435)
14. M.A. Zimmerman, J.F. Trotter, and M. Wachs Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience Transpl Int 20 2007 747 753 (Pubitemid 47221058)
15. K. Dudek, O. Kornasiewicz, and P. Remiszewski Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma Transplant Proc 41 2009 3135 3137
16. R.E. Schwarz, and D.D. Smith Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population Am J Surg 195 2008 829 836 (Pubitemid 351749460)
17. S.H. Kim, H.K. Lim, and D. Choi Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results AJR Am J Roentgenol 186 2006 S327 S333
18. U. Cillo, A. Vitale, and M. Bassanello Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma Ann Surg 239 2004 150 159 (Pubitemid 38176347)
19. U. Cillo, A. Vitale, and F. Grigoletto Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria Am J Transplant 7 2007 972 981 (Pubitemid 46481197)
20. M.E. Schwartz, F. D'Amico, and A. Vitale Liver transplantation for hepatocellular carcinoma: are the Milan criteria still valid? Eur J Surg Oncol 34 2008 256 262 (Pubitemid 351312865)
21. S. Jonas, W.O. Bechstein, and T. Steinmuller Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080 1086 (Pubitemid 32378206)
22. K.S. Suh, E.H. Cho, and H.W. Lee Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria Dig Dis 25 2007 329 333 (Pubitemid 350014961)
23. S.H. Yang, K.S. Suh, and H.W. Lee The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients Liver Transpl 12 2006 1655 1660 (Pubitemid 44742545)
24. J.I. Kim, J.M. Lee, and J.Y. Choi The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver Invest Radiol 43 2008 202 210 (Pubitemid 351643147)
25. Y.K. Kim, J.M. Lee, and C.S. Kim Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions Eur Radiol 14 2004 5 13 (Pubitemid 38181049)
26. R. Kuwatsuru, M. Kadoya, and K. Ohtomo Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors Invest Radiol 36 2001 632 641 (Pubitemid 33021091)
27. R. Manfredi, G. Maresca, and R.L. Baron Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA) J Magn Reson Imaging 9 1999 704 710 (Pubitemid 29211165)
28. K.G. Ishak, P.P. Anthony, and L.H. Solin Histological typing of tumors of the liver 2nd ed. 1994 Springer Berlin, Germany P. 20
29. H.A. Edmodson, and P.E. Steiner Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 1954 462 503
30. P.E. Shrout, and J.L. Fleiss Intraclass correlations: uses in assessing rater reliability Psychol Bull 86 1979 420 428
31. A. Spinazzi, V. Lorusso, and G. Pirovano Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers Acad Radiol 6 1999 282 291 (Pubitemid 32673373)
32. R. Caudana, G. Morana, and G.P. Pirovano Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)-preliminary results of phase II clinical application Radiology 199 1996 513 520
33. L. Grazioli, G. Morana, and M.A. Kirchin Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study Radiology 236 2005 166 177 (Pubitemid 40853309)
34. Y. Imai, T. Murakami, and S. Yoshida Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading Hepatology 32 2000 205 212 (Pubitemid 30614651)
35. K. Takeshita, I. Nagashima, and S. Frui Effect of superparamagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperplastic nodule J Comput Assist Tomogr 26 2002 451 455 (Pubitemid 34564228)
36. J.H. Kim, M.J. Kim, and Y.N. Park Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics Clin Radiol 63 2008 1195 1204
37. T. Murakami, R.L. Baron, and M.S. Peterson Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP) Radiology 200 1996 69 77
38. B.B. Frericks, C. Loddenkemper, and A. Huppertz Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA AJR Am J Roentgenol 193 2009 1053 1060
39. T.J. Vogl, A. Stupavsky, and W. Pegios Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation Radiology 205 1997 721 728 (Pubitemid 27516707)
40. L. Grazioli, G. Morana, and R. Caudana Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings Invest Radiol 35 2000 25 34 (Pubitemid 30033604)